Revenue | ₹45.70Cr |
Net Profits | ₹3.03Cr |
Net Profit Margins | 6.63% |
Kilitch Drugs (India) Ltd’s revenue jumped 26.84% since last year same period to ₹45.70Cr in the Q1 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -27.37% fall in its revenue since last 3-months.
Kilitch Drugs (India) Ltd’s net profit jumped 126.12% since last year same period to ₹3.03Cr in the Q1 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -70.87% fall in its net profits since last 3-months.
Kilitch Drugs (India) Ltd’s net profit margin jumped 78.27% since last year same period to 6.63% in the Q1 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated -59.89% fall in its net profit margins since last 3-months.
The revenue for Kilitch Drugs (India) Ltd in the Q1 results 2025 was ₹45.70Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q1 results 2025 was ₹3.03Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q1 results 2025 was 6.63%.
The revenue for Kilitch Drugs (India) Ltd in the Q1 results 2024 was ₹36.03Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q1 results 2024 was ₹1.34Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q1 results 2024 was 3.72%.